Provided by Tiger Trade Technology Pte. Ltd.

IceCure Medical Ltd.

2.27
-0.1600-6.58%
Post-market: 2.270.00000.00%19:23 EDT
Volume:656.19K
Turnover:1.58M
Market Cap:7.78M
PE:-0.34
High:2.38
Open:2.38
Low:2.18
Close:2.43
52wk High:42.00
52wk Low:2.12
Shares:3.43M
Float Shares:2.20M
Volume Ratio:2.30
T/O Rate:29.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.6592
EPS(LYR):-7.1047
ROE:-228.31%
ROA:-73.88%
PB:0.65
PE(LYR):-0.32

Loading ...

Icecure Medical Ltd trading halted, volatility trading pause

TIPRANKS
·
Jun 22

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:45 AM

Reuters
·
Jun 22

3 Penny Stocks to Watch Now, 6/18/2026

TIPRANKS
·
Jun 18

IceCure Medical Shares Jump After Update on Commercial Adoption of Breast Cancer Cryoablation Procedures

MT Newswires Live
·
Jun 18

Why Is IceCure Medical Stock (ICCM) Up Today?

TIPRANKS
·
Jun 18

IceCure prices USD 5.5 million private placement at USD 3 a share

Reuters
·
Jun 18

Icecure Announces Pricing of $5.5 Million Private Placement Priced at a Premium to the Market Price With a Single Healthcare Focused Institutional Investor

THOMSON REUTERS
·
Jun 18

BUZZ-U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron

Reuters
·
Jun 17

IceCure Medical business ‘moving in the right direction,’ says Brookline

TIPRANKS
·
Jun 17

BUZZ-IceCure on track for biggest one-day rise as FDA-cleared breast tumor treatment gains traction in U.S.

Reuters
·
Jun 17

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:54 AM

Reuters
·
Jun 17

IceCure reports 70% growth in active US commercial install base after FDA clearance for breast cancer cryoablation

Reuters
·
Jun 17

Icecure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance

THOMSON REUTERS
·
Jun 17

Icecure Medical Ltd trading halted, news pending

TIPRANKS
·
Jun 04

IceCure Medical Executes 1-for-30 Reverse Stock Split to Meet Nasdaq Listing Rules

Deep News
·
Jun 03

IceCure Medical announces 1-for-30 reverse share split to regain Nasdaq compliance

Reuters
·
Jun 02

Icecure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance

THOMSON REUTERS
·
Jun 02

Icecure Medical Earnings Call Highlights Growth Momentum

TIPRANKS
·
May 20

IceCure Showcases Strong ProSense® Cryoablation Data and Surge in Clinical Interest at ECIO 2026

TIPRANKS
·
May 19

IceCure ProSense kidney cancer trial shows 89.4% recurrence-free rate at 4 years

Reuters
·
May 19